Gene · 6358
Papers2,754
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,754
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative multi-omics and machine learning reveals the spatial niche distribution and role of CYP27A1+TAMs in immunotherapy response in non-small cell lung cancer. | Front Immunol | 2026 | 41836417 | PubTator, text mining | PubMed |
| Identification of core genes mediating the association between obesity and hepatocellular carcinoma: A bioinformatics study based on mitochondrial metabolism and immune pathways. | PLoS One | 2026 | 41801960 | PubTator, text mining | PubMed |
| Prognostic, chemotherapy and immunotherapy roles of GPR37/GPR37L1 in pan-cancer. | Medicine (Baltimore) | 2026 | 41790623 | PubTator, text mining | PubMed |
| Fat promotes growth and invasion in a 3D microfluidic tumor model of triple-negative breast cancer. | APL Bioeng | 2026 | 41789349 | PubTator, text mining | PubMed |
| What new renal biomarkers tell us about renal physiology: Collection: physiology applied to ICU. | Ann Intensive Care | 2026 | 41788482 | PubTator, text mining | PubMed |
| Decoding organ fibrosis: mechanistic insights and emerging therapeutic strategies. | Signal Transduct Target Ther | 2026 | 41786685 | PubTator, text mining | PubMed |
| Disruption of neutrophil homeostasis is associated with functional alterations in mitochondria of critically ill COVID-19 patients. | Sci Rep | 2026 | 41764210 | PubTator, text mining | PubMed |
| HER2-Low Breast Cancer: Biological Framework and Determinants of HER2 Instability. | Medicina (Kaunas) | 2026 | 41752702 | PubTator, text mining | PubMed |
| Hesperetin, Acting Through Inhibition of c-Jun Signaling, Mitigates Hypomyelinating Disease-Associated Stop-Loss Claudin-11-Induced Defective Morphogenesis in Oligodendroglial FBD-102b Cells. | Int J Mol Sci | 2026 | 41752091 | PubTator, text mining | PubMed |
| Annurca Apple By-Products at Different Ripening Stages Inhibit AGE Formation and Protect Against AGE-Induced Cytotoxicity Through Antioxidant Activity. | Antioxidants (Basel) | 2026 | 41750581 | PubTator, text mining | PubMed |
| The Role of Rarely Studied Chemokines in Tumor Progression in Multiple Myeloma (MM). | Cancers (Basel) | 2026 | 41749925 | PubTator, text mining | PubMed |
| Interpretable Machine Learning Identifies Key Inflammatory and Morphological Drivers of Intracranial Aneurysm Rupture Risk. | Bioengineering (Basel) | 2026 | 41749765 | PubTator, text mining | PubMed |
| ENN A1 and B1 In Vitro Toxicological Effects on 2D and 3D Organ-on-Chip HepaRG Liver Cells. | Toxins (Basel) | 2026 | 41745773 | PubTator, text mining | PubMed |
| The Role of APOL1 in Necrotizing Enterocolitis and Its Promise as a Diagnostic Biomarker. | Mediators Inflamm | 2026 | 41743217 | PubTator, text mining | PubMed |
| Single-cell transcriptomics revealed molecular vulnerability in a human midbrain-like organoid model of Parkinson's disease. | iScience | 2026 | 41727181 | PubTator, text mining | PubMed |
| Synergistic Enhancement of Non-viral SIRT1 Gene Delivery to Human Skin Equivalents Using Microneedling and Liposomal Vectors. | Cureus | 2026 | 41717169 | PubTator, text mining | PubMed |
| Persistent Severe Acute Kidney Injury Among Critically Ill Patients: Outcomes and Predictive Markers-A Single-Center Retrospective Cohort Study. | Crit Care Res Pract | 2026 | 41710101 | PubTator, text mining | PubMed |
| ΔNp63α drives serine synthesis to promote carboplatin resistance in NSCLC. | Cell Death Dis | 2026 | 41702885 | PubTator, text mining | PubMed |
| Correction: Met Is the Most Frequently Amplified Gene in Endometriosis-Associated Ovarian Clear Cell Adenocarcinoma and Correlates with Worsened Prognosis. | PLoS One | 2026 | 41701672 | PubTator, text mining | PubMed |
| Three-Dimensional Perspectives on Inflammatory Regulation in Coronary Atherosclerosis: Integrated Mechanisms of Endothelial Priming, Lipid Metabolism, and Cytokine Synergy. | Rev Cardiovasc Med | 2026 | 41659082 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6358/papers?page=2